Geiser-Vrtek Priscille, Soccal Paola Marina, Rochat Thierry
Service de médecine interne génerale, HUG, 1211 Genève 14.
Rev Med Suisse. 2008 Nov 19;4(180):2532-5.
Since most patients with cystic fibrosis (CF) die from respiratory failure, lung transplantation remains for many of them the ultimate treatment. The decision to put a patient on the transplantation waiting list is based on a list of criteria from international guidelines. We aimed to determine if a survival score could help determine when a CF patient has to be referred to a transplantation program. We applied this score to a small number of consecutive patients from our adult CF clinic, but found that it was of limited value for individual decision. Awareness of international guidelines and clinical judgement are essential to refer CF patients at proper time for lung transplantation.
由于大多数囊性纤维化(CF)患者死于呼吸衰竭,肺移植对他们中的许多人来说仍然是最终的治疗方法。将患者列入移植等候名单的决定基于国际指南中的一系列标准。我们旨在确定生存评分是否有助于确定CF患者何时需要转介至移植项目。我们将此评分应用于来自我们成人CF诊所的少数连续患者,但发现其对个体决策的价值有限。了解国际指南和临床判断对于在适当时间将CF患者转介进行肺移植至关重要。